RxDoctor Payments Data

Paul Scheatzle, DO

Physical Medicine & Rehabilitation · Canton, OHNPI 1447254321

Payments from drug & device makers

$1,574in general payments, 2019–2025

Across 25 payments — averaging $62.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$1K
  • Avanir Pharmaceuticals, Inc.$101
  • Collegium Pharmaceutical, Inc.$70
  • Novo Nordisk$69
  • Amarin Pharma, Inc.$66
  • Johnson & Johnson$62
  • plus $101 from 3 others

What the payments were for

  • Food & beverage$1,574100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,574 in reported general payments places this provider in the 75th percentile of 332 physical medicine & rehabilitation providers in Ohio.

See all physical medicine & rehabilitation providers in Ohio

Medicare billing

Part B allowed, 2024
$293,426
Medicare patients
505
Services billed
3,674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban71$40,277
JardianceEmpagliflozin24$12,900
XareltoRivaroxaban23$12,365
EntrestoSacubitril/Valsartan12$5,866
Enoxaparin Sodium15$1,252
Metoprolol Succinate104$1,050
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$986
Atorvastatin Calcium141$842
Pantoprazole Sodium102$814
Albuterol Sulfate HfaAlbuterol Sulfate25$602
Potassium Chloride47$587
Pregabalin13$456
Levothyroxine Sodium80$403
Bumetanide19$389
Levetiracetam24$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$35$12,90024 claims
Johnson & JohnsonXarelto$62$12,36523 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 332 physical medicine & rehabilitation providers in Ohio.

Other physical medicine & rehabilitation in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →